122 related articles for article (PubMed ID: 10225721)
1. Plasma constituents other than low-density lipoprotein adsorbed by dextran-sulfate column.
Kojima S; Harada-Shiba M; Yamamoto A
Ther Apher; 1997 Nov; 1(4):309-13. PubMed ID: 10225721
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein apheresis and changes in plasma components.
Kojima S
Ther Apher; 2001 Aug; 5(4):232-8. PubMed ID: 11724506
[TBL] [Abstract][Full Text] [Related]
3. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T
Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904
[TBL] [Abstract][Full Text] [Related]
4. Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis.
Murashima J; Ueki Y; Matsunaga Y; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
Blood Coagul Fibrinolysis; 1998 Nov; 9(8):725-32. PubMed ID: 9890715
[TBL] [Abstract][Full Text] [Related]
5. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column.
Kojima S; Harada-Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
ASAIO Trans; 1991; 37(4):644-8. PubMed ID: 1768503
[TBL] [Abstract][Full Text] [Related]
6. Contact activation in low-density lipoprotein apheresis systems.
Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
[TBL] [Abstract][Full Text] [Related]
7. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
Kojima S; Ogi M; Sugi T; Matsumoto Y; Yoshitomi Y; Kuramochi M
Ther Apher; 1997 Nov; 1(4):356-61. PubMed ID: 10225731
[TBL] [Abstract][Full Text] [Related]
9. Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis.
Kojima S; Shiba M; Kuramochi M; Yamamoto A
Artif Organs; 1995 Feb; 19(2):135-9. PubMed ID: 7763192
[TBL] [Abstract][Full Text] [Related]
10. Isolation of low density lipoprotein subfraction containing apolipoprotein B-like protein from Japanese eel Anguilla japonica plasma using dextran sulfate cellulose.
Ando S; Matsuzaki M
Comp Biochem Physiol B Biochem Mol Biol; 1997 Feb; 116(2):191-6. PubMed ID: 9159883
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
Koga N
Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
[TBL] [Abstract][Full Text] [Related]
12. Effects of losartan on low-density lipoprotein apheresis.
Kojima S; Yoshitomi Y; Saotome M; Tanaka K; Shida M; Kuramochi M
Ther Apher; 1999 Nov; 3(4):303-6. PubMed ID: 10608722
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A and P protein levels are lowered by dextran sulfate cellulose low-density lipoprotein apheresis.
Yoshidome H; Kuriyama M; Fujiyama J; Osame M
Artif Organs; 1998 Feb; 22(2):144-8. PubMed ID: 9491906
[TBL] [Abstract][Full Text] [Related]
14. Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles.
Wang JW; Zhang YN; Sze SK; van de Weg SM; Vernooij F; Schoneveld AH; Tan SH; Versteeg HH; Timmers L; Lam CSP; de Kleijn DPV
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286309
[TBL] [Abstract][Full Text] [Related]
15. Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system.
Tani N
Artif Organs; 1996 Aug; 20(8):922-9. PubMed ID: 8853808
[TBL] [Abstract][Full Text] [Related]
16. Anaphylactoid-like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric.
Adamski J; Jamensky L; Ross J; Siegel DL; Sachais BS
J Clin Apher; 2010; 25(6):354-7. PubMed ID: 20806416
[TBL] [Abstract][Full Text] [Related]
17. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
Mabuchi H; Michishita I; Takeda M; Fujita H; Koizumi J; Takeda R; Takada S; Oonishi M
Atherosclerosis; 1987 Nov; 68(1-2):19-25. PubMed ID: 2446636
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
19. LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia.
Olbricht CJ; Schulzeck P
ASAIO Trans; 1991; 37(3):M492-3. PubMed ID: 1751248
[TBL] [Abstract][Full Text] [Related]
20. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
